NCT02043886View on ClinicalTrials.gov

Acarbose, Postprandial Hypotension and Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2013

Study Completion Date

May 31, 2014

Conditions
Type 2 DiabetesPostprandial Hypotension
Interventions
DRUG

Acarbose

Acarbose 50 mg by mouth given during Meal Test

DRUG

Placebo

Non active substance matched to look like Acarbose 50 mg tablets. Taken by mouth during Meal Test.

Trial Locations (1)

V5Z1M9

VITALiTY Research Centre, Vancouver

All Listed Sponsors
collaborator

Canadian Diabetes Association

OTHER

lead

University of British Columbia

OTHER

NCT02043886 - Acarbose, Postprandial Hypotension and Type 2 Diabetes | Biotech Hunter | Biotech Hunter